Sung Pil Kwon

1.8k total citations · 1 hit paper
22 papers, 1.4k citations indexed

About

Sung Pil Kwon is a scholar working on Molecular Biology, Surgery and Infectious Diseases. According to data from OpenAlex, Sung Pil Kwon has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Surgery and 4 papers in Infectious Diseases. Recurrent topics in Sung Pil Kwon's work include RNA Interference and Gene Delivery (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Extracellular vesicles in disease (4 papers). Sung Pil Kwon is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Extracellular vesicles in disease (4 papers). Sung Pil Kwon collaborates with scholars based in South Korea, Sudan and Puerto Rico. Sung Pil Kwon's co-authors include Byung‐Soo Kim, Seuk Young Song, Mikyung Kang, Ju‐Ro Lee, Han Young Kim, Yeon Woong Choo, Mungyo Jung, Jihye Hong, Seokhyeong Go and Seokyung Kang and has published in prestigious journals such as Advanced Materials, Nano Letters and ACS Nano.

In The Last Decade

Sung Pil Kwon

22 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors

2018 381 citations Yeon Woong Choo, Mikyung Kang et al. ACS Nano profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sung Pil Kwon South Korea	15	705	499	442	232	207	22	1.4k
Seuk Young Song South Korea	18	890 1.3×	772 1.5×	531 1.2×	251 1.1×	304 1.5×	25	2.0k
Ju‐Ro Lee South Korea	16	621 0.9×	521 1.0×	277 0.6×	217 0.9×	233 1.1×	29	1.3k
Yeon Woong Choo South Korea	7	543 0.8×	475 1.0×	275 0.6×	195 0.8×	189 0.9×	7	1.1k
Marco Campisi United States	11	648 0.9×	604 1.2×	290 0.7×	257 1.1×	161 0.8×	14	1.6k
Marta I. Oliveira Portugal	18	632 0.9×	409 0.8×	355 0.8×	174 0.8×	139 0.7×	26	1.4k
Zhao Hai China	16	372 0.5×	307 0.6×	520 1.2×	106 0.5×	148 0.7×	58	1.2k
Mungyo Jung South Korea	14	510 0.7×	398 0.8×	483 1.1×	143 0.6×	126 0.6×	20	1.1k
Xinchi Jiang China	23	908 1.3×	518 1.0×	149 0.3×	237 1.0×	390 1.9×	41	1.6k
Ai Zhuang China	20	641 0.9×	274 0.5×	119 0.3×	313 1.3×	125 0.6×	49	1.3k
Yang Woo Kwon South Korea	20	774 1.1×	450 0.9×	122 0.3×	221 1.0×	271 1.3×	42	1.6k

Countries citing papers authored by Sung Pil Kwon

Since Specialization

Citations

This map shows the geographic impact of Sung Pil Kwon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung Pil Kwon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung Pil Kwon more than expected).

Fields of papers citing papers by Sung Pil Kwon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sung Pil Kwon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung Pil Kwon. The network helps show where Sung Pil Kwon may publish in the future.

Co-authorship network of co-authors of Sung Pil Kwon

This figure shows the co-authorship network connecting the top 25 collaborators of Sung Pil Kwon. A scholar is included among the top collaborators of Sung Pil Kwon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sung Pil Kwon. Sung Pil Kwon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Faisal, Muhammad, Hyo‐Jung Park, Sung Pil Kwon, et al.. (2025). Novel Less Toxic, Lymphoid Tissue‐Targeted Lipid Nanoparticles Containing a Vitamin B5‐Derived Ionizable Lipid for mRNA Vaccine Delivery (Adv. Healthcare Mater. 7/2025). Advanced Healthcare Materials. 14(7). 1 indexed citations

Kwon, Euna, Kang Min Han, Ji Eun Kim, et al.. (2024). Impact of administration routes and dose frequency on the toxicology of SARS-CoV-2 mRNA vaccines in mice model. Archives of Toxicology. 99(2). 755–773. 1 indexed citations

Faisal, Muhammad, Hyo‐Jung Park, Sung Pil Kwon, et al.. (2024). Novel Less Toxic, Lymphoid Tissue‐Targeted Lipid Nanoparticles Containing a Vitamin B5‐Derived Ionizable Lipid for mRNA Vaccine Delivery. Advanced Healthcare Materials. 14(7). e2403366–e2403366. 6 indexed citations

Lee, Ji Sun, Hyo‐Jung Park, Sung Pil Kwon, et al.. (2024). A lipid nanoparticle platform incorporating trehalose glycolipid for exceptional mRNA vaccine safety. Bioactive Materials. 38. 486–498. 22 indexed citations

Lee, Yu‐Sun, Sang‐In Park, Hyo‐Jung Park, et al.. (2023). Analysis of the Immunostimulatory Effects of Cytokine-Expressing Internal Ribosome Entry Site–Based RNA Adjuvants and Their Applications. The Journal of Infectious Diseases. 229(5). 1408–1418. 4 indexed citations

Kwon, Sung Pil, Woori Kwak, Sang‐In Park, et al.. (2023). Analyzing immune responses to varied mRNA and protein vaccine sequences. npj Vaccines. 8(1). 84–84. 21 indexed citations

Sohn, Hee Su, Jeong Won Choi, JooYeon Jhun, et al.. (2022). Tolerogenic nanoparticles induce type II collagen–specific regulatory T cells and ameliorate osteoarthritis. Science Advances. 8(47). eabo5284–eabo5284. 52 indexed citations

Kim, Cheesue, Songhyun Lim, Mungyo Jung, et al.. (2022). A Senolytic-Eluting Coronary Stent for the Prevention of In-Stent Restenosis. ACS Biomaterials Science & Engineering. 8(5). 1921–1929. 9 indexed citations

Lee, Ju‐Ro, Bong‐Woo Park, Jae-Hyun Park, et al.. (2021). Local delivery of a senolytic drug in ischemia and reperfusion-injured heart attenuates cardiac remodeling and restores impaired cardiac function. Acta Biomaterialia. 135. 520–533. 45 indexed citations

10.

Go, Seokhyeong, Mikyung Kang, Sung Pil Kwon, et al.. (2021). The Senolytic Drug JQ1 Removes Senescent Cells via Ferroptosis. Tissue Engineering and Regenerative Medicine. 18(5). 841–850. 29 indexed citations

11.

Kwon, Sung Pil, Seuk Young Song, Jin Yoo, et al.. (2021). Multilayered Cell Sheets of Cardiac Reprogrammed Cells for the Evaluation of Drug Cytotoxicity. Tissue Engineering and Regenerative Medicine. 18(5). 807–818. 5 indexed citations

12.

Kang, Mikyung, Seong Ho Lee, Junho Byun, et al.. (2021). Nanocomplex‐Mediated In Vivo Programming to Chimeric Antigen Receptor‐M1 Macrophages for Cancer Therapy. Advanced Materials. 33(43). e2103258–e2103258. 154 indexed citations

13.

Kwon, Sung Pil, Byung‐Hee Hwang, Eunhye Park, et al.. (2021). Nanoparticle‐Mediated Blocking of Excessive Inflammation for Prevention of Heart Failure Following Myocardial Infarction. Small. 17(32). e2101207–e2101207. 39 indexed citations

14.

Lee, Ju‐Ro, Bong‐Woo Park, Jonghoon Kim, et al.. (2020). Nanovesicles derived from iron oxide nanoparticles–incorporated mesenchymal stem cells for cardiac repair. Science Advances. 6(18). eaaz0952–eaaz0952. 145 indexed citations

15.

Kang, Mikyung, Jihye Hong, Mungyo Jung, et al.. (2020). T‐Cell‐Mimicking Nanoparticles for Cancer Immunotherapy. Advanced Materials. 32(39). e2003368–e2003368. 103 indexed citations

16.

Lee, Ju‐Ro, Jae Won Kyung, Hemant Kumar, et al.. (2020). Targeted Delivery of Mesenchymal Stem Cell-Derived Nanovesicles for Spinal Cord Injury Treatment. International Journal of Molecular Sciences. 21(11). 4185–4185. 52 indexed citations

17.

Kim, Han Young, Mikyung Kang, Yeon Woong Choo, et al.. (2019). Immunomodulatory Lipocomplex Functionalized with Photosensitizer-Embedded Cancer Cell Membrane Inhibits Tumor Growth and Metastasis. Nano Letters. 19(8). 5185–5193. 84 indexed citations

18.

Kim, Han Young, Hemant Kumar, Min‐Jae Jo, et al.. (2018). Therapeutic Efficacy-Potentiated and Diseased Organ-Targeting Nanovesicles Derived from Mesenchymal Stem Cells for Spinal Cord Injury Treatment. Nano Letters. 18(8). 4965–4975. 158 indexed citations

19.

Choo, Yeon Woong, Mikyung Kang, Han Young Kim, et al.. (2018). M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors. ACS Nano. 12(9). 8977–8993. 381 indexed citations breakdown →

20.

Yoon, Jeong‐Kee, Mrinmoy Misra, Seung Jung Yu, et al.. (2017). Thermosensitive, Stretchable, and Piezoelectric Substrate for Generation of Myogenic Cell Sheet Fragments from Human Mesenchymal Stem Cells for Skeletal Muscle Regeneration. Advanced Functional Materials. 27(48). 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact